However, further research is needed to determine whether the loss of ATRX is associated with epigenetic landscape reprogramming, as well as increased levels of telomerase reverse transcriptase (TERT) and alternative lengthening of telomeres (ALT) expression, in glioma subtypes [19, 20]. Here, ATRX is linked to central nervous system cancer.